managing all patients who relapse after transplantation
Published 2 years ago • 344 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
2:34
improving outcomes for patients who relapse after allosct & evaluating cd19 cars against emd in all
-
2:38
emerging strategies for the management of relapsed aml
-
2:06
managing relapsed all: the role of novel cellular therapies & importance of conditioning regimens
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
2:11
acute lymphoblastic leukaemia (all): life after treatment
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
9:44
what to expect during your inpatient allogeneic stem cell transplant
-
1:34
single-center study evaluating the outcomes of patients with aml who relapsed after allosct
-
1:38
future treatment strategies for r/r ph all
-
2:46
optimizing preceding and consolidation therapies to prevent post-car-t relapse in b-all
-
3:16
developing patient-specific mrd markers for predicting and preventing mds relapse post-sct
-
2:19
maintaining remission in aml and improving long-term survival in patients who do not receive hsct
-
1:48
do all patients require maintenance therapy following allosct?
-
1:31
how the treatment and management of all changes with age
-
1:21
the remnant study: will treating patients at mrd relapse improve survival outcomes?
-
0:58
management strategies for acute and chronic gvhd following allosct
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
2:45
continuity of care for patients with hematological predispositions to aml
-
2:02
recent advances in all treatment
-
1:33
sorafenib as maintenance therapy for patients with transplant-ineligible or post-allosct aml
-
1:53
how novel agents may eliminate the need for transplant in all